Preclinical Pharmacodynamic Characterization of STK-026: A Novel IL-12 Partial Agonist for Cancer with Maintained CD8 T cell Activity, Reduced NK-mediated Toxicity and an Improved Therapeutic Window
STK-026
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preclinical Pharmacodynamic Characterization of STK-026: A Novel IL-12 Partial Agonist for Cancer with Maintained CD8 T cell Activity, Reduced NK-mediated Toxicity and an Improved Therapeutic Window ### Output: STK-026